Literature DB >> 12719681

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.

Geoffrey R Norman1, Jeff A Sloan, Kathleen W Wyrwich.   

Abstract

BACKGROUND: A number of studies have computed the minimally important difference (MID) for health-related quality of life instruments.
OBJECTIVE: To determine whether there is consistency in the magnitude of MID estimates from different instruments.
METHODS: We conducted a systematic review of the literature to identify studies that computed an MID and contained sufficient information to compute an effect size (ES). Thirty-eight studies fulfilled the criteria, resulting in 62 ESs.
RESULTS: For all but 6 studies, the MID estimates were close to one half a SD (mean = 0.495, SD = 0.155). There was no consistent relationship with factors such as disease-specific or generic instrument or the number of response options. Negative changes were not associated with larger ESs. Population-based estimation procedures and brief follow-up were associated with smaller ESs, and acute conditions with larger ESs. An explanation for this consistency is that research in psychology has shown that the limit of people's ability to discriminate over a wide range of tasks is approximately 1 part in 7, which is very close to half a SD.
CONCLUSION: In most circumstances, the threshold of discrimination for changes in health-related quality of life for chronic diseases appears to be approximately half a SD.

Entities:  

Mesh:

Year:  2003        PMID: 12719681     DOI: 10.1097/01.MLR.0000062554.74615.4C

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  1347 in total

1.  Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery.

Authors:  C Quinten; C Kenis; L Decoster; P R Debruyne; I De Groof; C Focan; F Cornelis; V Verschaeve; C Bachmann; D Bron; S Luce; G Debugne; H Van den Bulck; J C Goeminne; A Baitar; K Geboers; B Petit; C Langenaeken; R Van Rijswijk; P Specenier; G Jerusalem; J P Praet; K Vandenborre; M Lycke; J Flamaing; K Milisen; J P Lobelle; H Wildiers
Journal:  Qual Life Res       Date:  2018-12-03       Impact factor: 4.147

2.  Analysis of factors associated with electing endoscopic sinus surgery.

Authors:  Adam S DeConde; Jess C Mace; Vijay R Ramakrishnan; Jeremiah A Alt; Timothy L Smith
Journal:  Laryngoscope       Date:  2017-08-04       Impact factor: 3.325

3.  Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis.

Authors:  Jennifer L Barton; John Imboden; Jonathan Graf; David Glidden; Edward H Yelin; Dean Schillinger
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06       Impact factor: 4.794

4.  Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.

Authors:  Weidong Lu; Anita Giobbie-Hurder; Rachel A Freedman; Im Hee Shin; Nancy U Lin; Ann H Partridge; David S Rosenthal; Jennifer A Ligibel
Journal:  Oncologist       Date:  2019-10-14

5.  Low-Fat Dietary Pattern Intervention and Health-Related Quality of Life: The Women's Health Initiative Randomized Controlled Dietary Modification Trial.

Authors:  Annlouise R Assaf; Shirley A A Beresford; Patricia Markham Risica; Aaron Aragaki; Robert L Brunner; Deborah J Bowen; Michelle Naughton; Milagros C Rosal; Linda Snetselaar; Nanette Wenger
Journal:  J Acad Nutr Diet       Date:  2015-09-16       Impact factor: 4.910

Review 6.  Do 8- to 18-year-old children/adolescents with chronic physical health conditions have worse health-related quality of life than their healthy peers? a meta-analysis of studies using the KIDSCREEN questionnaires.

Authors:  Neuza Silva; Marco Pereira; Christiane Otto; Ulrike Ravens-Sieberer; Maria Cristina Canavarro; Monika Bullinger
Journal:  Qual Life Res       Date:  2019-05-04       Impact factor: 4.147

7.  Performance of the Asthma Impact on Quality of Life Scale (A-IQOLS) in diverse asthma research populations and demographic subgroups.

Authors:  Sandra R Wilson; Robert A Wise; Mario Castro; Michael J Mulligan; Estela Ayala; Alan Chausow; Qiwen Huang; Santosh Gummidipundi
Journal:  J Allergy Clin Immunol       Date:  2018-05-04       Impact factor: 10.793

8.  Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument.

Authors:  H Jacobi; M Rakowicz; R Rola; R Fancellu; C Mariotti; P Charles; A Dürr; M Küper; D Timmann; C Linnemann; L Schöls; O Kaut; C Schaub; A Filla; L Baliko; B Melegh; J-S Kang; P Giunti; B P C van de Warrenburg; R Fimmers; T Klockgether
Journal:  Cerebellum       Date:  2013-06       Impact factor: 3.847

9.  Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.

Authors:  Maria Jose Catalan; Jose Antonio Molina-Arjona; Pablo Mir; Esther Cubo; Jose Matias Arbelo; Pablo Martinez-Martin
Journal:  J Neurol       Date:  2018-03-20       Impact factor: 4.849

10.  Improvement in patient-reported outcomes after lung transplantation is not impacted by the use of extracorporeal membrane oxygenation as a bridge to transplantation.

Authors:  Nicholas A Kolaitis; Allison Soong; Pavan Shrestha; Hanjing Zhuo; John Neuhaus; Patti P Katz; John R Greenland; Jeffrey Golden; Lorriana E Leard; Rupal J Shah; Steven R Hays; Jasleen Kukreja; Mary Ellen Kleinhenz; Paul D Blanc; Jonathan P Singer
Journal:  J Thorac Cardiovasc Surg       Date:  2018-02-22       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.